Argenx
ARGX
#443
Rank
A$78.65 B
Marketcap
A$1,259
Share price
0.18%
Change (1 day)
40.77%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): A$23.66

According to Argenx 's latest financial reports the company's current EPS (TTM) is A$22.51. In 2024 the company made an earnings per share (EPS) of A$19.82 an increase over its 2023 EPS that were of A-$7.35.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$23.66
2024A$19.82-369.77%
2023A-$7.35-60.46%
2022A-$18.5863.33%
2021A-$11.38-40.37%
2020A-$19.08183.47%
2019A-$6.73123.09%
2018A-$3.0254.93%
2017A-$1.9514.07%
2016A-$1.7113.05%
2015A-$1.51-36.34%
2014A-$2.37209.04%
2013A-$0.77-33.99%
2012A-$1.16185.59%
2011A-$0.41